Standard Leukemia care

OTHER2 trials

Sponsors

Massachusetts General Hospital

Conditions

Acute Myeloid LeukemiaMyelodysplastic Syndromes

Unknown Phase

A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia

CompletedNCT02975869

Massachusetts General HospitalAcute Myeloid Leukemia

Start: 2017-01-01End: 2026-01-01Updated: 2026-03-03

A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy

Active, not recruitingNCT03310918

Massachusetts General HospitalAcute Myeloid Leukemia, Myelodysplastic Syndromes

Start: 2017-10-31End: 2026-12-31Target: 320Updated: 2026-04-06

Related Papers

Multi-site randomized trial of a collaborative palliative and oncology care model for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) receiving non-intensive therapy.

Journal of Clinical Oncology2024-06-05

Trajectories of physical well-being among adults with acute myeloid leukemia

Blood Advances2024-03-02

Palliative care and coping in patients with acute myeloid leukemia receiving intensive induction therapy: A mediation analysis of data from a randomized trial.

Journal of Clinical Oncology2021-05-20

Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia

JAMA Oncology2020-12-18165 citations

Patient Experiences with Liposomal Daunorubicin and Cytarabine (CPX-351) Versus Conventional Induction Regimens: An Analysis of Patient-Reported Outcomes Data from a Prospective Trial

Blood2020-11-043 citations

Multisite randomized trial of integrated palliative and oncology care for patients with acute myeloid leukemia (AML).

Journal of Clinical Oncology2020-05-2015 citations